Replies to post #49567 on Ayala Pharmaceuticals Inc (fka ADXS)

[equaloppforall]

I appreciate that, Ig. In any case, both you and I know that the chance of the Jan call options being anything other than worthless is zero.

Also, while the company did say the EU filing will happen before Q1 2018, I am leaning more and more towards the possibility of the company being sold, considering their deafening silence for this long as well as Lombardo's track record in prior CEO positions. I can only hope we like the buyout number. We'll see.